TAK — TAKEDA PHARMACEUTICAL CO LTD
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1395064 ·
Last close
$21.64
Market Cap
$69.11B
52W High
$21.86
52W Low
$13.91
ADV30
3,041,509
Next earnings
2027-01-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 1,187,097,000,000 | 795,004,000,000 | 205,322,000,000 | 192,429,000,000 | 15,271,498,000,000 | 418,533,000,000 | 7,854,322,000,000 |
| Jun 2026 | 1,219,900,000,000 | 813,224,000,000 | 201,417,000,000 | 113,197,000,000 | 15,663,271,000,000 | 460,982,000,000 | 8,104,395,000,000 |
| Mar 2026 | 1,094,541,000,000 | 688,837,000,000 | 42,068,000,000 | -368,471,000,000 | 15,511,506,000,000 | 595,054,000,000 | 8,080,857,000,000 |
| Dec 2025 | 1,191,698,000,000 | 790,550,000,000 | 168,822,000,000 | 103,640,000,000 | 15,408,774,000,000 | 654,937,000,000 | 7,764,684,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$879,671,000,000
Investing CF
$-396,589,000,000
Financing CF
$-761,309,000,000
CapEx
$-445,724,000,000
Dividends Paid
$-315,684,000,000
Buybacks
$-1,007,000,000
EPS Diluted TTM
$74.39
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$859,247,000,000
Inventory
$1,441,087,000,000
Receivables
$910,245,000,000
ST Investments
$35,868,000,000
EBIT TTM
$82,580,000,000
Pretax Income TTM
$-2,471,000,000
Interest Exp TTM
$85,051,000,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,618,934,812,672
EBITDA
$1,249,335,967,744
Free Cash Flow
$541,443,883,008
Enterprise Value
$5,134,218,690,560
Total Cash
$460,981,993,472
Total Debt
$5,536,499,105,792
Shares Out
3,193,502,878
Trailing EPS
$-0.34
Book Value
$15.57
ROE
-2.3%
ROA
2.7%
Div Yield
3.38%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 4,505,720,000,000 | 464,451,000,000 | -152,390,000,000 | 15,511,506,000,000 | 8,080,857,000,000 | 7,429,441,000,000 | 1,041,431,000,000 |
| Mar 2025 | 4,581,551,000,000 | 466,370,000,000 | 107,928,000,000 | 14,248,344,000,000 | 7,312,365,000,000 | 6,935,084,000,000 | 1,057,182,000,000 |
| Mar 2024 | 4,263,762,000,000 | 309,901,000,000 | 144,067,000,000 | 15,108,792,000,000 | 7,834,787,000,000 | 7,273,264,000,000 | 716,344,000,000 |
| Mar 2023 | 4,027,478,000,000 | 587,812,000,000 | 317,017,000,000 | 13,957,750,000,000 | 7,603,079,000,000 | 6,354,122,000,000 | 977,156,000,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.53
Max Pain — expiry 2027-04-16
max pain strike: $17.50 · spot: $21.27 · call oi: 1,243 · put oi: 98Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | $49.73B | $42.62 | — |
| REGN | REGENERON PHARMACEUTICALS, INC. | $97.34B | $957.76 | — |
| GSK | GSK plc | $98.62B | $49.24 | — |
| ONC | BeOne Medicines Ltd. | $43.55B | $413.26 | — |
| SNY | Sanofi | $113.89B | $47.53 | — |
News headlines (Yahoo Finance, 1h cache)
Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Thursday Trading
2026-11-12 15:44 · Yahoo
Takeda Launches ORZEYFUL™ (oveporexton), the First and Only Medicine of Its Kind for Narcolepsy Type 1 Now Available in the United States
2026-11-12 12:35 · Yahoo
What Takeda Pharmaceutical (TAK) Said on Its Q2 Earnings Call
2026-10-30 11:14 · Yahoo
Takeda (TAK) Q2 2026 Earnings Call Transcript
2026-10-29 17:45 · Yahoo
Asian Equities Traded in the US as American Depositary Receipts Start Week Sharply Lower in Monday Trading
2026-11-16 15:48 · Yahoo
Raised Guidance Could Change The Case For Schrödinger Stock (SDGR)
2026-11-07 20:12 · Yahoo
Royalty Pharma Q3 Earnings Call Highlights
2026-11-04 20:14 · Yahoo
6 Big Funds Sold Zoetis. Should You Follow Them Before Earnings?
2026-11-04 11:57 · Yahoo
Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading
2026-10-30 14:40 · Yahoo
Novavax Eyes New Partnerships as Sanofi Advances COVID-Flu Vaccine Trial
2026-11-17 21:12 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.